Parecoxib sodium alleviates ischemia reperfusion‐induced pulmonary injury via inhibiting ERK/NF‐κB and further activating the HIF‐1α pathway
Open Access
- 17 August 2022
- journal article
- research article
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 10 (9) , e684
Abstract
Introduction: The lungs are extremely vulnerable to ischemia/reperfusion (I/R), which is characterized by intense inflammation, oxidative stress, alveolar damage, and vascular permeability. Parecoxib sodium (Pare) has been shown to exert protective effects against multiple I/R‐induced tissue injuries. However, its role in I/R‐induced lung injury remains unknown. This study aimed to reveal the roles and mechanisms of Pare in pulmonary I/R injury.Methods: Sixty‐six rats were randomly divided into three groups: The sham‐operated group, the pulmonary I/R group, and the Pare‐pretreated I/R group. Pare at 10 mg/kg or saline (vehicle control) were intraperitoneally administered to rats once per day for 5 consecutive days before ischemia. Serum and tissue samples were harvested following 2 h of reperfusion. The oxygenation index (OI) and alveolar‐arterial oxygen partial pressure difference (PA‐aO2) were analyzed. The levels or activities of malondialdehyde, superoxidase dismutase, catalase, glutathione peroxidase, intracellular reactive oxygen species, tumor necrosis factor‐α, interleukin (IL)‐6, and IL‐8 were examined. The mitochondrial membrane potential was measured. The protein expression levels of the extracellular signal‐regulated kinase (ERK), nuclear factor‐κB (NF‐κB) and their phosphorylated forms, and hypoxia‐inducible factor‐1α (HIF‐1α) were detected. Histological changes were observed using hematoxylin and eosin staining. Moreover, the survival rate following pulmonary I/R injury was recorded daily.Results: Pare significantly increased the OI, decreased the PA‐aO2, increased the levels of antioxidants, while decreasing the levels of oxidants, and alleviated mitochondrial dysfunction and the histopathological damage induced by I/R. Furthermore, Pare inhibited the expression of proinflammatory cytokines, suppressed the activation of ERK and NF‐κB, further increased HIF‐1α expression, and significantly improved the rat survival rate.Conclusions: Pare pretreatment attenuated lung I/R injury by inhibiting oxidative stress and the inflammatory response possibly via inhibiting the activation of the ERK/NF‐κB pathway and further activating the HIF‐1α pathway.Keywords
This publication has 48 references indexed in Scilit:
- Regulation of Hypoxia-Inducible Factor-1a by Reactive Oxygen Species : New Developments in an Old DebateJournal of Cellular Biochemistry, 2015
- Pretreatment with sildenafil alleviates early lung ischemia-reperfusion injury in a rat modelJournal of Surgical Research, 2013
- Molecular Mechanisms of Ischemia–Reperfusion Injury in Brain: Pivotal Role of the Mitochondrial Membrane Potential in Reactive Oxygen Species GenerationMolecular Neurobiology, 2012
- Suppression of NF-κB pathway by crocetin contributes to attenuation of lipopolysaccharide-induced acute lung injury in miceEuropean Journal of Pharmacology, 2012
- Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and DiseasesAntioxidants & Redox Signaling, 2011
- Regulation of Metabolism by Hypoxia-Inducible Factor 1Cold Spring Harbor Symposia on Quantitative Biology, 2011
- Mechanisms of the noxious inflammatory cycle in cystic fibrosisRespiratory Research, 2009
- Cyclosporine Modulates the Response to Hypoxia-Reoxygenation in Pulmonary Artery Endothelial CellsThe Annals of Thoracic Surgery, 2005
- Early tumor necrosis factor-α release from the pulmonary macrophage in lung ischemia-reperfusion injuryThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8Nature, 1993